SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients.

Abstract

SPECT-guided CT was able to clarify more than 90% of SPECT findings classified as indeterminate in an analysis that was masked as to clinical pretest probability and the planar scan findings. Further studies carefully addressing the cost efficiency of this new technology and its actual clinical value are encouraged by this observation.